| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| South Korea Peripheral Vascular Devices Market Size 2023 |
USD 41.25 Million |
| South Korea Peripheral Vascular Devices Market, CAGR |
3.62% |
| South Korea Peripheral Vascular Devices Market Size 2032 |
USD 54.80 Million |
Market Overview
The South Korea Peripheral Vascular Devices Market is projected to grow from USD 41.25 million in 2023 to USD 54.80 million by 2032, at a CAGR of 3.62%.
The South Korea Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery diseases (PAD) and the growing aging population, which significantly raises the demand for advanced vascular treatments. Technological innovations, such as minimally invasive procedures and the development of more efficient devices, are enhancing the treatment options for vascular disorders, further contributing to market growth. Additionally, the government’s healthcare reforms and initiatives to improve the accessibility of medical treatments are positively influencing the market. Rising awareness about PAD and the benefits of early detection and treatment are driving the demand for peripheral vascular devices. Furthermore, the growing adoption of advanced imaging technologies and robotics in vascular procedures is accelerating market expansion. These factors, combined with the rapid advancement of medical infrastructure, are positioning the South Korea market as a key player in the global peripheral vascular device industry.
The South Korea Peripheral Vascular Devices market is characterized by a strong presence of key players such as Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and Nipro Corporation, among others. These companies play a significant role in driving the market with their innovative product offerings, including angioplasty balloons, stents, and guidewires. The market is concentrated in regions like Seoul Metropolitan and Gyeonggi, where advanced healthcare infrastructure and high patient demand for peripheral vascular treatments are prevalent. Additionally, growing adoption of minimally invasive procedures and advancements in device technologies are contributing to the market’s expansion. Other players such as Cook Medical, Asahi Intecc Co., Ltd., and B. Braun Melsungen AG also contribute significantly to the competitive landscape, offering a wide range of devices designed to improve vascular treatment outcomes. These companies are key drivers in making South Korea a leading market for peripheral vascular devices in the Asia-Pacific region.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Insights
- The South Korea Peripheral Vascular Devices market was valued at USD 41.25 million in 2023 and is projected to reach USD 54.80 million by 2032, growing at a CAGR of 3.62%.
- Increasing prevalence of peripheral artery diseases (PAD) is driving the demand for peripheral vascular devices in South Korea.
- The shift towards minimally invasive procedures is boosting the adoption of angioplasty balloons and stents.
- Technological advancements in device designs, such as drug-eluting stents, are contributing to market growth.
- High device costs and regulatory delays pose significant restraints to market expansion.
- The Seoul Metropolitan Region and Gyeonggi Province dominate the market, driven by advanced healthcare infrastructure.
- Major players such as Terumo Corporation, Medtronic plc, and Boston Scientific Corporation are key contributors to the competitive landscape.
Market Drivers
Rising Prevalence of Peripheral Artery Diseases (PAD)
One of the key drivers of the South Korea Peripheral Vascular Devices market is the increasing incidence of peripheral artery diseases (PAD). As the population ages, the risk of PAD, which occurs due to narrowed arteries, is rising. For instance, a study reported that the prevalence of PAD in South Korea increased from 3.93 per 1,000 persons in 2011 to 23.55 per 1,000 persons in 2018. This condition is common among individuals aged 60 and above, and with South Korea’s aging population, the need for effective treatments and devices is growing. The demand for peripheral vascular devices to treat PAD is thus expanding, driving market growth.
Technological Advancements in Medical Devices
Technological innovations in peripheral vascular devices are significantly fueling market expansion in South Korea. The development of minimally invasive procedures, such as angioplasty and stenting, has enhanced the effectiveness and safety of vascular treatments. Newer devices designed for precision and faster recovery times are gaining popularity, making them more attractive to both healthcare providers and patients. Additionally, advancements in materials and device designs, such as drug-eluting stents and covered stents, have contributed to improving patient outcomes, further increasing the adoption of these devices.
Government Healthcare Initiatives
Government support for healthcare reforms and initiatives plays a crucial role in driving the growth of the peripheral vascular device market in South Korea. The government has been focused on improving the healthcare infrastructure and providing better access to advanced medical treatments. With an emphasis on the expansion of healthcare services, particularly for vascular diseases, the market for peripheral vascular devices benefits from favorable policies and reimbursement schemes. For instance, the South Korean government’s National Health Insurance Service provides universal coverage, ensuring that advanced medical treatments are accessible to all citizens. These efforts make the devices more accessible to a broader segment of the population, accelerating market demand.
Growing Awareness and Patient Education
Growing awareness about the risks of PAD and the benefits of early detection and intervention is driving the demand for peripheral vascular devices in South Korea. Public health campaigns and educational programs are increasing knowledge about vascular diseases, leading to more patients seeking treatment for PAD at earlier stages. Additionally, healthcare professionals are becoming more proactive in diagnosing vascular conditions, contributing to the increasing use of these devices. As awareness grows, the demand for innovative and effective peripheral vascular devices is expected to continue rising in the coming years.
Market Trends
Shift Toward Minimally Invasive Procedures
A significant trend in the South Korea Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. These treatments, such as angioplasty, stent implantation, and atherectomy, offer faster recovery times, reduced complications, and less patient discomfort compared to traditional open surgeries. As a result, both healthcare providers and patients are increasingly opting for these innovative procedures. For instance, a report highlighted that approximately 150,000 interventional cardiology procedures are performed annually in South Korea, making up nearly 75% of all cardiac procedures in the country. The shift toward minimally invasive techniques is driving the demand for advanced vascular devices designed for precision and efficiency, contributing to the market’s expansion.
Adoption of Advanced Imaging Technologies
The integration of advanced imaging technologies in peripheral vascular procedures is another key trend influencing the market. Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are enhancing the ability to visualize blood vessels and guide interventions with higher precision. These tools allow for better planning and monitoring during procedures, resulting in improved outcomes and reduced risks. The increasing adoption of these imaging technologies is facilitating the use of more advanced peripheral vascular devices, thereby supporting market growth in South Korea.
Growth in the Elderly Population
With South Korea’s aging population, there is an ongoing trend of increasing healthcare demands, particularly for treatments related to age-related conditions like peripheral artery disease (PAD). Older adults are more likely to experience vascular issues, prompting greater reliance on peripheral vascular devices. For instance, by 2025, South Korea is expected to become a “super-aged society,” with over 20 percent of the population being 65 years or older. The aging demographic is also leading to longer life expectancies, which in turn increases the need for long-term vascular care and interventions. This growing segment of the population is driving the demand for a wide range of vascular devices, which is further stimulating market growth.
Focus on Drug-Eluting Devices
A rising trend in the South Korea Peripheral Vascular Devices market is the increasing use of drug-eluting devices. These devices, which release medication to prevent restenosis or re-narrowing of blood vessels, are gaining popularity due to their ability to improve long-term outcomes. Drug-eluting stents, in particular, are becoming more commonly used in peripheral vascular interventions, as they help reduce the need for repeat procedures and improve patient recovery. As medical professionals and patients seek more effective treatments, the demand for drug-eluting devices continues to rise, driving market trends.
Market Challenges Analysis
High Cost of Advanced Devices
One of the primary challenges facing the South Korea Peripheral Vascular Devices market is the high cost of advanced devices. While technological advancements have led to the development of more efficient and precise devices, they often come with a significantly higher price tag. This can create affordability issues for healthcare providers, especially smaller hospitals and clinics, limiting access to the latest vascular treatments. Additionally, patients may face financial barriers when it comes to out-of-pocket expenses, even with government reimbursement programs in place. For instance, a report by the South Korean Medical Device Industry Association highlighted that the high cost of advanced medical devices is a significant barrier for many healthcare providers in the region. The high cost of cutting-edge devices may restrict their widespread adoption, slowing market growth and limiting the accessibility of advanced treatment options for peripheral vascular diseases.
Regulatory and Approval Delays
Regulatory hurdles and delays in product approvals present another challenge to the South Korea Peripheral Vascular Devices market. The process for obtaining regulatory clearance for new devices can be lengthy and complex, often leading to delays in the introduction of innovative products to the market. Manufacturers must navigate a stringent approval process, including clinical trials and compliance with national and international standards. These delays can slow down the pace of technological advancement in the industry, limiting the timely availability of new and improved vascular devices for healthcare providers. For instance, the Ministry of Food and Drug Safety (MFDS) in South Korea has a rigorous approval process that can delay the introduction of new medical devices. Moreover, the complexity of regulatory frameworks can deter smaller companies from entering the market, consolidating market power in the hands of a few large players.
Market Opportunities
Expansion of Healthcare Infrastructure
A significant opportunity for the South Korea Peripheral Vascular Devices market lies in the expansion of healthcare infrastructure. The government’s focus on improving the healthcare system, including the establishment of more advanced medical centers and the upgrade of existing facilities, creates a favorable environment for the adoption of cutting-edge vascular devices. As the healthcare infrastructure continues to grow, particularly in rural and underserved areas, there is increased potential for the adoption of advanced peripheral vascular treatments. This expansion will allow peripheral vascular devices to reach a broader patient base, driving demand and fostering market growth.
Growing Demand for Preventive and Minimally Invasive Treatments
Another key opportunity in the South Korea Peripheral Vascular Devices market is the increasing demand for preventive care and minimally invasive treatments. With a rising awareness of the importance of early detection and intervention for peripheral artery diseases (PAD), patients are seeking more proactive treatment options. This trend is further supported by a growing preference for minimally invasive procedures that offer shorter recovery times and fewer complications compared to traditional surgeries. As patients become more health-conscious and as healthcare providers seek to offer more efficient treatment options, the market for peripheral vascular devices designed for minimally invasive procedures will continue to expand. Manufacturers can capitalize on this shift by developing innovative, cost-effective devices that cater to this growing demand for advanced, patient-friendly vascular treatments.
Market Segmentation Analysis:
By Type:
The South Korea Peripheral Vascular Devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and stents are the most widely used devices, driven by their essential role in treating peripheral artery diseases (PAD) through minimally invasive procedures. Angioplasty balloons are used to open narrowed blood vessels, while stents are implanted to keep arteries open and prevent restenosis. Catheters and guidewires are integral tools used in conjunction with these devices to guide and facilitate the insertion and placement of stents and balloons. As the demand for minimally invasive procedures increases, the market for these devices is expected to grow. Other peripheral vascular devices, which include atherectomy devices and thrombectomy devices, also contribute to the market but represent a smaller share. Manufacturers continue to innovate within these segments to improve the effectiveness and precision of treatments, further driving the demand for peripheral vascular devices in South Korea.
By End-user:
The South Korea Peripheral Vascular Devices market is further segmented by end-user, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market due to their advanced infrastructure and the capacity to handle complex vascular surgeries and treatments. The increasing number of PAD cases and the growing adoption of minimally invasive procedures in hospitals contribute to the sector’s growth. Ambulatory surgical centers are also witnessing a rise in the use of peripheral vascular devices as patients increasingly prefer outpatient care for procedures such as angioplasty and stent placements. Specialty clinics, focusing on vascular diseases, are emerging as important players in providing specialized care and treatment for PAD, which further supports market growth. As patient preferences shift toward cost-effective and efficient treatment options, the demand for peripheral vascular devices across these end-user segments will continue to increase, driving the market forward.
Segments:
Based on Type:
- Angioplasty Balloons
- Angioplasty Stents
- Catheters
- Guidewires
- Others
Based on End-user:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Based on the Geography:
- Seoul Metropolitan Region
- Gyeonggi Province
- Busan and Ulsan Regions
- Daegu Region
Regional Analysis
Seoul Metropolitan Region
The Seoul Metropolitan Region holds the largest market share in the South Korea Peripheral Vascular Devices market, accounting for approximately 45% of the total market. This region is home to the capital city, Seoul, which is the healthcare and medical hub of the country. The area boasts a high concentration of advanced healthcare facilities, including top-tier hospitals, medical research institutions, and specialized clinics. The demand for peripheral vascular devices in this region is driven by the large patient population, the rising prevalence of peripheral artery diseases (PAD), and the increasing adoption of minimally invasive procedures. Moreover, the presence of leading healthcare professionals, cutting-edge medical technologies, and the continuous advancement of healthcare infrastructure further supports the dominance of the Seoul Metropolitan Region in the market.
Gyeonggi Province
Gyeonggi Province follows closely with a 30% market share in the South Korea Peripheral Vascular Devices market. As the province surrounding Seoul, Gyeonggi benefits from proximity to the capital’s medical resources while also developing its own healthcare sector. The growing demand for peripheral vascular devices in Gyeonggi is fueled by the increasing number of hospitals, specialty clinics, and ambulatory surgical centers (ASCs) in the area. Additionally, the population density and the aging demographic in Gyeonggi contribute to the rising incidence of vascular diseases, particularly peripheral artery diseases, which further increases the need for advanced vascular devices. The province’s strong healthcare infrastructure and the expansion of medical services make it a key player in the market.
Busan and Ulsan Regions
The Busan and Ulsan regions, with a combined market share of 15%, are emerging as important contributors to the South Korea Peripheral Vascular Devices market. Busan, being the second-largest city in the country, has seen a significant increase in healthcare facilities and specialized medical centers in recent years. The region’s strong economic position and its role as a major port city also contribute to the expansion of healthcare services. Similarly, Ulsan, an industrial hub, has experienced growth in medical infrastructure, particularly in hospitals and outpatient centers offering vascular treatments. The increasing demand for treatment of peripheral artery diseases in these regions, combined with the growing adoption of minimally invasive procedures, drives the need for advanced peripheral vascular devices.
Daegu Region
The Daegu region, with a market share of 10%, has a smaller but still significant presence in the South Korea Peripheral Vascular Devices market. Daegu, known for its thriving medical sector, has seen steady growth in the healthcare industry, with a focus on providing specialized treatment for various chronic diseases, including peripheral artery disease (PAD). The region’s hospitals and medical centers are increasingly incorporating peripheral vascular devices into their treatment offerings. Although the market share in Daegu is comparatively lower than that of the Seoul Metropolitan and Gyeonggi provinces, the rising aging population and the growing awareness of vascular diseases contribute to the steady increase in demand for peripheral vascular devices. The region’s healthcare infrastructure and increasing number of specialized vascular clinics support the growing adoption of these devices.
Key Player Analysis
- Terumo Corporation
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Nipro Corporation
- Cook Medical
- Asahi Intecc Co., Ltd.
- Braun Melsungen AG
- MicroPort Scientific Corporation
- Cardinal Health
Competitive Analysis
The South Korea Peripheral Vascular Devices market is highly competitive, with key players such as Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health leading the industry. Leading companies in this market are focusing on developing advanced devices such as drug-eluting stents, angioplasty balloons, and catheters to meet the needs of patients suffering from peripheral artery diseases (PAD). Competitive strategies involve the continuous improvement of product designs, incorporating cutting-edge technologies like intravascular ultrasound and optical coherence tomography, which enhance treatment precision and patient outcomes. Furthermore, companies are increasingly focusing on expanding their market share through mergers, acquisitions, and strategic collaborations with healthcare providers. Partnerships with hospitals and ambulatory surgical centers are also crucial for gaining a competitive edge in the market. To address the demand for cost-effective solutions, companies are investing in the development of affordable vascular devices, ensuring that more healthcare facilities can adopt these technologies. For instance, the South Korean government’s focus on preventive healthcare and early diagnosis has led to increased demand for diagnostic and therapeutic devices. With the increasing prevalence of PAD and the shift toward outpatient care, there is growing competition to provide innovative, high-quality products that offer better outcomes for patients while ensuring reduced recovery times and minimal complications.
Recent Developments
- In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
- In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
- In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
- In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.
Market Concentration & Characteristics
The South Korea Peripheral Vascular Devices market is moderately concentrated, with a mix of dominant players and emerging companies. The market is primarily led by multinational corporations that bring advanced technological innovations and extensive product portfolios to meet the growing demand for peripheral artery disease (PAD) treatments. These key players benefit from established brand recognition, substantial R&D investments, and wide distribution networks. However, the market also features increasing participation from local manufacturers, which are introducing more cost-effective solutions, making the competition more dynamic. The market is characterized by a high degree of innovation, with a continuous focus on developing minimally invasive devices that offer improved treatment outcomes and faster recovery times. As the demand for devices like angioplasty balloons, stents, and catheters grows, companies are investing in the development of drug-eluting and biodegradable stents, as well as advanced guidewires and catheters. Additionally, there is a trend toward personalized medicine, with devices becoming more tailored to specific patient needs and conditions. The South Korean healthcare sector’s emphasis on improving patient outcomes and reducing hospital stays supports the market’s focus on minimally invasive technologies. Overall, the market is becoming increasingly competitive, with a balance between global leaders and local innovators striving to cater to the diverse needs of healthcare providers and patients.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage
The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The South Korea Peripheral Vascular Devices market is expected to continue growing due to an aging population and an increasing prevalence of peripheral artery disease (PAD).
- Demand for minimally invasive procedures will drive the adoption of advanced vascular devices like angioplasty balloons and stents.
- Technological innovations, such as drug-eluting and biodegradable stents, will enhance treatment outcomes and patient recovery.
- The market will see a shift toward personalized treatment options, with devices designed to cater to specific patient needs.
- Continued government investments in healthcare infrastructure will support the growth of the market.
- Expansion of outpatient care centers and ambulatory surgical centers will increase demand for peripheral vascular devices.
- Manufacturers will focus on improving product affordability to cater to a broader range of healthcare providers and patients.
- Collaborations between medical device companies and healthcare providers will boost access to advanced vascular treatments.
- The development of advanced guidewires, catheters, and diagnostic technologies will further optimize minimally invasive vascular interventions.
- The South Korea market will benefit from an increase in healthcare awareness, with more patients seeking early diagnosis and treatment for PAD.
